首页> 外国专利> MARKERS AND THEIR RATIO TO DETERMINE THE RISK FOR EARLY-ONSET PREECLAMPSIA

MARKERS AND THEIR RATIO TO DETERMINE THE RISK FOR EARLY-ONSET PREECLAMPSIA

机译:标记和它们的比率来确定早发性青光眼的风险

摘要

The application discloses new biomarkers for early-onset preeclampsia based on the finding that the ratio between GBP-1 and ESM-1 in plasma samples was significantly increased in women that develop severe early-onset pre-eclampsia compared to healthy control pregnancies: the ratio between GBP-1 and ESM-1 is a prognostic parameter to identify the women at risk for severe early- onset pre-eclampsia as early as 12±2 weeks of gestation and can serve both as an important rule-in and rule-out parameter.
机译:该申请公开了一种新的早发型先兆子痫的生物标志物,基于以下发现:与健康对照孕妇相比,患有严重的早发型先兆子痫的女性血浆样品中GBP-1和ESM-1的比例显着增加: GBP-1和ESM-1之间的差值是确定早在妊娠12±2周时有严重早发先兆子痫风险的女性的预后参数,并且可以用作重要的入选和排除参数。

著录项

  • 公开/公告号WO2017217844A1

    专利类型

  • 公开/公告日2017-12-21

    原文格式PDF

  • 申请/专利权人 IQ PRODUCTS B.V.;

    申请/专利号WO2017NL50392

  • 发明设计人 SCHUITEMAKER JOOST HENRIC NICOLAAS;

    申请日2017-06-14

  • 分类号G01N33/50;G01N33/68;

  • 国家 WO

  • 入库时间 2022-08-21 12:46:46

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号